On Jun. 1, 2020, PathGroup announced the availability of a new, minimally-invasive nasal swab collection option as a part of its comprehensive SARS-CoV-2 (COVID-19) testing program. The new nasal swab collection option is more comfortable for patients and easier for healthcare providers to administer.